Jaemin Lee is a Vice President and Head of the Life Science Global Strategy Team at Samsung Ventures, where he identifies innovative Life Science companies across the U.S. and Europe. He leverages his extensive expertise to identify and invest in groundbreaking technologies, with a primary focus on areas such as antibody drug conjugates, gene & cell therapy, and AI-driven drug discovery. Prior to joining Samsung Ventures in 2018, he served as a Principal Scientist at Samsung Bioepis from 2014 to 2018, and before that, as a Senior Researcher at both GC Pharma and Hanmi Pharmaceuticals. His educational background includes a Ph.D. candidate in Management of Technology from Korea University, an M.S. in Molecular and Life Science from Pohang University of Science and Technology (POSTECH), and a B.S. in Life and Genetic Engineering from Korea University.